COYA

Coya Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

6.0%

Short % Float

5.2d to cover · Moderate squeeze

33.3%

Inst % Float

10 holders · 2026-06-30

DME Capital Manage

Top Holder

10.0% of float

17.8M sh

Public Float

37/100

Dilution Score

Medium

57 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

37/100

MEDIUM

Inst: 33.27% · Top: DME Capital Management, LP

Biotech Analytics

Biotech / Pharma

26.43

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications75

Dilution Risk37

Clinical Trials38

Short Interest30